Filed before 2025Filed 26 March 2020
Nurix Therapeutics, Inc. raised $120M
Nurix Therapeutics, Inc., a company based in San Francisco, CA, raised $120M in a new equity round, according to a filing dated 26 March 2020.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 26 March 2020
- Round
- Equity round
- Amount sold
- $120M
- Offering size
- $120M
- Investors so far
- 23
- Based in
- San Francisco, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 96% of the 1,744 tracked raises with an amount filed in 2020.
Nurix Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 26 Mar 2020 | New filing | $120M | This raise |
| 18 Sep 2015 | New filing | $17M | Another raise |
| 2 Jan 2014 | New filing | $2.08M | Another raise |
More with 6 Dimensions Capital on the board
- Plexium, Inc.$60.1M
- Vivace Therapeutics, Inc.$17.5M
- Eikon Therapeutics, Inc.$351M
- Seranova Bio, Inc.$10M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.